These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
157 related items for PubMed ID: 37030471
1. Antimalarials and amphotericin B interact synergistically and are new options to treat cryptococcosis. Freitas GJC, Ribeiro NQ, Gouveia-Eufrasio L, Emidio ECP, Guimarães GM, César IC, Paixão TA, Oliveira JBS, Caza M, Kronstad JW, Santos DA. Int J Antimicrob Agents; 2023 Jul; 62(1):106807. PubMed ID: 37030471 [Abstract] [Full Text] [Related]
4. Antifungal and antibiofilm effect of duloxetine hydrochloride against Cryptococcus neoformans and Cryptococcus gattii. Rehem AR, da Gama Viveiro LR, De Souza Santos EL, do Carmo PHF, da Silva NS, Junqueira JC, Scorzoni L. Folia Microbiol (Praha); 2024 Dec; 69(6):1247-1254. PubMed ID: 38652436 [Abstract] [Full Text] [Related]
5. N-acetylcysteine reduces amphotericin B deoxycholate nephrotoxicity and improves the outcome of murine cryptococcosis. Magalhães TFF, Costa MC, Holanda RA, Ferreira GF, Carvalho VSD, Freitas GJC, Ribeiro NQ, Emídio ECP, Carmo PHF, de Brito CB, de Souza DG, Rocha CEV, Paixão TA, de Resende-Stoianoff MA, Santos DA. Med Mycol; 2020 Aug 01; 58(6):835-844. PubMed ID: 31919505 [Abstract] [Full Text] [Related]
7. Brilacidin, a novel antifungal agent against Cryptococcus neoformans. Diehl C, Pinzan CF, de Castro PA, Delbaje E, García Carnero LC, Sánchez-León E, Bhalla K, Kronstad JW, Kim D-g, Doering TL, Alkhazraji S, Mishra NN, Ibrahim AS, Yoshimura M, Vega Isuhuaylas LA, Pham LTK, Yashiroda Y, Boone C, Dos Reis TF, Goldman GH. mBio; 2024 Jul 17; 15(7):e0103124. PubMed ID: 38916308 [Abstract] [Full Text] [Related]
8. Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts. Spadari CC, Vila T, Rozental S, Ishida K. Antimicrob Agents Chemother; 2018 Aug 17; 62(8):. PubMed ID: 29844051 [Abstract] [Full Text] [Related]
9. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods. Nishikawa MM, Almeida-Paes R, Brito-Santos F, Nascimento CR, Fialho MM, Trilles L, Morales BP, da Silva SA, Santos W, Santos LO, Fortes ST, Cardarelli-Leite P, Lázera MDS. Med Mycol; 2019 Oct 01; 57(7):864-873. PubMed ID: 30657975 [Abstract] [Full Text] [Related]
12. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the Cryptococcus neoformans Complex in Jiangxi Province, South Central China. Yang C, Bian Z, Blechert O, Deng F, Chen H, Li Y, Yang Y, Chen M, Zhan P. Front Cell Infect Microbiol; 2021 Oct 01; 11():723251. PubMed ID: 34790585 [Abstract] [Full Text] [Related]
16. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp. Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O. Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099 [Abstract] [Full Text] [Related]